Biomarkers in Cancer Detection and Monitoring of Therapeutics
Volume 2: Diagnostic and Therapeutic Applications
- Publisher's listprice EUR 144.00
-
59 724 Ft (56 880 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 11 945 Ft off)
- Discounted price 47 779 Ft (45 504 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
59 724 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Science
- Date of Publication 28 November 2023
- ISBN 9780323951142
- Binding Paperback
- No. of pages600 pages
- Size 234x190 mm
- Weight 1400 g
- Language English 516
Categories
Long description:
Molecular Biomarkers in Cancer Detection and Monitoring of Therapeutics: Volume Two: Diagnostic and Therapeutic Applications discusses how molecular biomarkers are used to determine predisposition, facilitate detection, improve treatment and offer prevention guidelines for different cancers. It focuses on novel diagnostic techniques based on molecular biomarkers and their impact on treatment, covering different cancer types such as tumors in the nervous system, head and neck, oral and GI tractor, lung, breast, gastric system, leukemia and urogenital tract cancers. For each type, the book discusses the best diagnostic techniques and therapeutic approaches, thus helping readers easily identify the best solution for each case.
This is a valuable resource for cancer researchers, oncologists, graduate students and other members of the biomedical field who are interested in the potential of biomarkers in cancer research.
Table of Contents:
1. SKIN CANCER BIOLOGY AND ITS BIOMARKERS:RECENT TRENDS AND PROSPECTIVE
Himani Sharma
2. ROLE OF BIOMARKERS IN ASSESSING RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN CANCER TREATMENT
Shyam Aggarwal
3. GENOTYPE INFLUENCED PHARMACOKINETICS OF ANTI-CANCER MEDICINE: A CONNECTING LINK
Shamsher Singh
4. GENETIC PREDISPOSITION AND PATHOPHYSIOLOGY OF ORAL SQUAMOUS CELL CARCINOMA
Gowtham Kumar Subbaraj
5. ORAL SQUAMOUS CELL CARCINOMA
Anubha Gulati
6. SHARED AND DISTINCT ASPECTS OF HEMATOPOIETIC MALIGNANCIES SUCH AS LEUKEMIA AND LYMPHOMA
Ramakrishnan Veerabathiran
7. MOLECULAR DIAGNOSIS, DRIVERS AND TREATMENT LYMPHOCYTIC LEUKEMIA
Saurabh Yadav
8. MYELODYSPLASTIC SYNDROME - A CHALLENGING ENTITY
Anshu Palta
9. MULTIPLE MYELOMA
Vijay Goni
10. MOLECULAR BIOMARKERS IN PROSTATE CANCER
KATSUNORI UCHIDA and Remi Semba
11. GENETICS OF NEURONAL AND GLIONEURONAL CANCERS
Anshika Srivastava
12. RECENT ADVANCEMENT IN MOLECULAR MARKER OF PANCREATIC CANCER
Kanagaraj Palaniyandi
13. MOLECULAR BIOMARKERS IN GASTRIC CANCER
Yoshifumi S. Hirokawa and Kazuki Kanayama
14. MOLECULAR BIOMARKERS IN PANCREATIC DUCTAL ADENOCARCINOMA
Yoshifumi S. Hirokawa, Reiko Yamada and Junya Tsuboi
15. BIOMARKERS IN ENDOMTRIAL AND CERVICAL CANCER
Aashima Arora
16. BIOMARKERS IN ENDOCRINE DISEASES
Sunil Chumber and Dhritiman Maitra
17. CANCER IMMUNOTHERAPY ASSOCIATED ENDOCRINE COMPLICATIONS
Kousik Pramanick
18. THERAPEUTIC POTENTIAL OF MELATONIN IN GLIOBLASTOMA: CURRENT KNOWLEDGE AND FUTURE PROSPECTS
Nithar Ranjan Madhu Sr.
19. ANTICANCER ACTIVITIES OF MACROMOLECULES OFMARINE ORIGIN: CLINICAL EVIDENCE
Maushmi Shailesh Kumar
20. NANOPARTICLES AS A MEANS OF DRUG DELIVERY IN CANCER THERAPY
Olorunfemi Raphael Molehin
21. THERAPEUTIC POTENTIAL OF MICROALGAE AND THEIR PROSPECTS IN TARGETED DELIVERY IN CANCER MANAGEMENT
Maushami Kumar and Maushmi Shailesh Kumar
22. PROSPECTS OF MANGROVE DERIVED PHYTOCHEMICALS IN CANCER RESEARCH
Punarbasu Choawdhury
23. PHYTOCHEMICALS AND MIRNA BASED THERAPEUTIC OPPORTUNITIES FOR CANCER STEM CELL MEDIATED TUMOR ANGIOGENESIS
Anandan Balakrishnan
24. EMERGENCE OF METAL-BASED ANTICANCER THERAPEUTICS: A PROMISING PERSPECTIVE
Suman Adhikari
25. NEW INFRARED (NIR) RESPONSE NANOMATERIAL LIPOSOME NANOHYBRID FOR CANCER PHOTO THERMAL
Animesh Pan
26. IMPACT OF PESTICIDES ON IMMUNE-ENDOCRINE DISORDERS AND ITS RELATIONSHIP TO CANCER DEVELOPMENT
Carolina Panis
